News & Articles

Molecular diagnostics experts share why EQCs are no longer optional if you’re looking to elevate your molecular diagnostics

New portfolio enhancements reflect Bruker’s commitment to advancing integrated, high‑performance solutions that support laboratories in addressing evolving infectious disease challenges

Watchmaker Genomics presented new data highlighting the performance of its amplification technologies, including the Stellar RT-qPCR and qPCR Kits, at ESCMID 2026

After years of research, gene therapy is entering clinics worldwide, bringing new expectations and new responsibilities for diagnostic laboratories

Discover how SelectScience clinical CE webinars are supporting biomedical scientists and laboratory professionals in achieving diagnostic excellence during Medical Lab Professionals Week 2026

In this guest editorial, Richard Knight Senior Director, Medical Affairs, Thermo Fisher Scientific, explores how success in transplantation is measured in years, not hours, and how lab professionals provide the critical data needed to navigate the high-stakes journey of post-operative care

National Institutes of Health awards The Research OutSmarts Endometriosis team an $850,000 prize over one year to accelerate the development of a non-invasive diagnostic test

Forage Evolution co-founder Cameron Kitzinger talks with SelectScience to celebrate Medical Laboratory Professionals Week 2026

As part of Lab Professionals Week, Aida Noor shares what it means to build a biomedical science career beyond the bench

Through a real-world patient story, CLSI explores how laboratory medicine can shape diagnosis and care in complex cases.

In this guest editorial, Jon Sherlock, Senior Director, Product Management at Thermo Fisher Scientific explores why supporting laboratory professionals is the key to bridging the gap between innovation and patient outcomes

At-home self-collection reduces significant barriers for unscreened or under-screened individuals

Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and treatments

Minimally invasive blood test enables greater patient access to monitoring of neuroinflammatory status versus current standard of care methods

BIOFIRE SPOTFIRE introduces a simple, small and smart approach to mycoplasma detection, helping biopharmaceutical manufacturers strengthen quality control, accelerate decision-making, and protect patients

Dr. Barbara Jones, CEO of CLSI, discusses emerging resistance trends, the importance of updated breakpoints, and how CLSI continues to support laboratories navigating the evolving AMR landscape

Discover how free software can help design oligos for PCR assays, reducing guesswork and enabling creation of effective diagnostic assays

Toni Ertl shares how The Native Antigen Company’s new human health recombinant proteins are advancing assay development in diagnostics and vaccine research

The cobas c 703 and cobas ISE neo analytical units deliver higher testing capacity and increased automation, helping to improve laboratory workflows and advance patient care

Guest editorial by Eric Pabon, MBA Senior Manager, Global Product Marketing Hematology, Beckman Coulter

Join the online session for practical solutions for accurate sampling, handling, and analysis

The test currently under development by MicrosensDx involves the detection of the oxidized form of a novel biomarker that indicates the risk of severe sepsis

The partnership is guided by a shared belief that engineering excellence ultimately serves one purpose: to improve patient care

SCCM 2026 presentation reports 19% reduction in sepsis mortality and double-digit operational improvements across four hospitals

Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases